We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

73 hedge funds and large institutions have $117M invested in Windtree Therapeutics Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

66% more call options, than puts

Call options by funds: $636K | Put options by funds: $383K

22% more funds holding

Funds holding: 6073 (+13)

2.41% more ownership

Funds ownership: 61.63%64.04% (+2.4%)

6% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 17

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $117M → $117M (-$562K)

Holders
73
Holders Change
+13
Holders Change %
+21.67%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
18
Reduced
17
Closed
5
Calls
$636K
Puts
$383K
Net Calls
+$253K
Net Calls Change
+$194K

WINT Hedge Fund Activity: Q1 2014 in Review

73 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2014, worth a combined $117M — down 0.48% from $117M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new WINT positions and 5 closed out — a net gain of 14 holders — while 18 added to existing stakes and 17 trimmed.

The largest buyer was Tamarack Capital Management, adding an estimated $1.81M. The largest seller was Wells Fargo, cutting an estimated $3.26M.

  • 73 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2014, up from 60 in Q4 2013.
  • Funds reported $117M of Windtree Therapeutics Inc stock for Q1 2014, down 0.48% quarter-over-quarter.
  • 19 funds opened new Windtree Therapeutics Inc positions in Q1 2014 and 5 closed out, a net change of +14 holders.
  • The largest Windtree Therapeutics Inc buyer in Q1 2014 was Tamarack Capital Management, an estimated $1.81M added.
  • The largest Windtree Therapeutics Inc seller in Q1 2014 was Wells Fargo, an estimated $3.26M sold.

Based on aggregated 13F filings for Q1 2014.